GlassScriptPhysician profile
Kevin P Davis
NPI 1043266794
$32,488.99
in general payments reported to CMS, 2019-2025
6 companies · $30.12 in 2025
The $30.12 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $9,007 · 2021: $6,963 · 2022: $914 · 2023: $2,865 · 2025: $30.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Travel and Lodging: $1,003 · Food and Beverage: $92.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $1,003.03 |
| Food and Beverage | $92.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,107.52 | 2019-2021 | |
| Medicaroid, INC. | $10,111.30 | 2021-2023 | |
| Clovis Oncology, INC. | $110.13 | 2019 | |
| Genentech USA, INC. | $102.26 | 2019 | |
| Stryker Corporation | $30.12 | 2025 | Actishield |
| Astrazeneca Pharmaceuticals LP | $27.66 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.